News Search Results
Apr 15, 2026, 08:21 ET Jones Appoints Soumit Roy, PhD, as Managing Director, Investment Banking
thoughtful, high-impact advice across the biotechnology sector."Moe Cohen, Head of Investment Banking at Jones, added: "Soumit's move to investment banking underscores the depth of expertise within our firm. His experience and insight in biotechnology will be instrumental as we continue to expand
More news about: JonesTrading Institutional Services
Apr 15, 2026, 08:00 ET Wobble Genomics to Present Novel mRNA Sequencing Research at AACR 2026
forefront of translational science and therapeutic development during the conference.About Wobble GenomicsWobble Genomics is a biotechnology company developing advanced RNA sequencing technologies to unlock deeper biological insights and enable more precise, data-driven approaches to
More news about: Wobble Genomics
Apr 15, 2026, 08:00 ET Kazia Therapeutics Strengthens Scientific Leadership with Appointment of Dr. Sudha Rao as Chief Scientific Officer to Lead Next-Generation Oncology Platform
Rao is a highly accomplished translational scientist and biotech executive with more than 20 years of experience spanning pharmaceutical R&D, biotechnology, and early clinical development. She currently holds a professorial appointment and leads the Gene Regulation and Translational Medicine Laboratory
More news about: Kazia Therapeutics Limited
Apr 14, 2026, 17:45 ET Partner Therapeutics announces submission of supplemental Biologics License Application (sBLA) to FDA for BIZENGRI® (zenocutuzumab-zbco) in NRG1 Fusion Positive Cholangiocarcinoma and Inclusion in updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
Mass., April 14, 2026 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announces the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for BIZENGRI
More news about: Partner Therapeutics, Inc.
Apr 14, 2026, 09:00 ET Vella Bioscience Brings Precision to CBD With Pleasurewave™
Inc. is a female health innovator dedicated to advancing women's sexual, hormonal, and intimate wellness through rigorous science and proprietary biotechnology. Built on scientific rigor and developed by the same team behind Viagra® and Cialis®, Vella addresses critical gaps in women's health research with
More news about: Vella Bioscience
Apr 14, 2026, 09:00 ET The Galien Foundation Announces 2026 Galien UK Forum - Future Health Disrupted: From Discovery to Delivery
evening at the Natural History Museum, London, which recognises outstanding achievements across several award categories, including "Best Biotechnology Product", "Best Digital Health Solution", "Best Medical Technology", "Best Pharmaceutical Product", "Best
More news about: The Galien Foundation
Apr 14, 2026, 08:36 ET Spiral Therapeutics Announces $27 Million Series B Financing and Strategic Partnership with Advanced Bionics
treatment paradigms across multiple otologic indications.About Spiral TherapeuticsSpiral Therapeutics is a clinical-stage biotechnology company focused on developing novel therapies for inner ear disorders, including hearing loss and balance disorders. Spiral's MICS™ (Minimally-Invasive
More news about: Spiral Therapeutics, Inc.
Apr 14, 2026, 08:32 ET Spirographic AI LLC Launches Tissue-Specific Polypharmacology Platform Demonstrating Industry-Leading Drug Target Prediction Accuracy
Spirographic AI, LLC is an early-stage biotechnology company developing computational tools for pharmaceutical drug discovery and safety prediction. The company's tissue-specific polypharmacology platform
More news about: Spirographic AI, LLC
Apr 14, 2026, 08:30 ET PhaseV Sponsors Timmerman Traverse in Support of the Damon Runyon Cancer Research Foundation
patients faster."The Timmerman Traverse is organized and led by Luke Timmerman, founder and editor of the Timmerman Report, a leading biotechnology newsletter. Since 2023 more than $3 million has been raised for the Damon Runyon Cancer Research Foundation, with 100% of the funds going to support
More news about: PhaseV
Apr 14, 2026, 08:02 ET GlycoNex Receives PMDA Approval in Japan to Initiate First-in-Human Phase 1 Trial of GNX1021 in Gastrointestinal Cancers
Taiwan, April 14, 2026 /PRNewswire/ -- GlycoNex, Inc. (4168, hereinafter referred to as GNX), clinical stage biotechnology company focused on the development of glycan-directed cancer immunotherapies, today announced that Japan's Pharmaceuticals and Medical Devices Agency
More news about: GlycoNex, Inc.
Apr 14, 2026, 08:00 ET GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report
SUSTAINABLE GROWTH IN BIOTECHNOLOGYThe 2025 ESG Report underscores GenScript's continued focus on aligning business growth with responsible practices, as the company expands its global presence and contributes to the evolution of a more resilient and accountable biotechnology sector.This
More news about: GenScript Biotech Corporation
Apr 14, 2026, 08:00 ET GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report
SUSTAINABLE GROWTH IN BIOTECHNOLOGYThe 2025 ESG Report underscores GenScript's continued focus on aligning business growth with responsible practices, as the company expands its global presence and contributes to the evolution of a more resilient and accountable biotechnology sector.This
More news about: GenScript Biotech Corporation
Apr 14, 2026, 08:00 ET Origin Agritech Launches Redesigned Corporate Website to Better Serve Partners, Customers, and Investors
Delivering an Enhanced Digital Experience Showcasing the Company's Agricultural Biotechnology Leadership, Product Portfolio, and Investor ResourcesBEIJING, April 14, 2026 /PRNewswire/ -- Origin
More news about: Origin Agritech Limited
Apr 14, 2026, 08:00 ET TOBY Receives FDA Breakthrough Device Designation for Its Urine-Based Multi-Cancer Early Detection (MCED) Test
AUSTIN, Texas, April 14, 2026 /PRNewswire/ -- TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough
More news about: TOBY, Inc.
Apr 14, 2026, 07:34 ET Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders
April 14, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on immunology research and diagnostics, today published a shareholder letter from Chief Executive Officer James Foster and released
More news about: Virax BioLabs Group Limited
Apr 14, 2026, 07:00 ET Epicutis Clinical Study Shows 77% Improvement in Skin Appearance -- With Zero Irritation
Epicutis®, the professional skincare brand powered by patented biotechnology from Signum Biosciences, today announced the launch of
More news about: Epicutis
Apr 14, 2026, 06:00 ET Adcendo ApS Completes $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline
(Jeito Capital) and Rajul Jain (Vida Ventures) to its Board of Directors.About Adcendo ApS: Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts. The company is developing a pipeline of first- and potential
More news about: Adcendo
Apr 14, 2026, 06:00 ET Adcendo ApS Completes $75 Million Series C Financing to Continue Advancing First- and Best-in-class Clinical ADC Pipeline
(Jeito Capital) and Rajul Jain (Vida Ventures) to its Board of Directors.About Adcendo ApS: Adcendo ApS is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark, with operations in Boston, Massachusetts. The company is developing a pipeline of first- and potential
More news about: Adcendo
Apr 14, 2026, 06:00 ET Harbinger Health Establishes RESOLVE™ as a New Category for Cancer Detection
Harbinger Health, a biotechnology company pioneering cancer resolution, today announced RESOLVE™, a new category of blood-based multi-cancer detection tests designed to bring clarity
More news about: Harbinger Health
Apr 14, 2026, 05:50 ET Green Surfactants And Emulsifiers Market Set to Reach USD 2.73 Bn by 2035 as Sustainable Chemistry and Bio-Based Innovations Accelerate Global Industry Transformation: - Market Research Intellect
adoption of environmentally responsible cleaning solutions worldwide.4. Advancements in Green Chemistry and BiotechnologyTechnological progress in biotechnology and green chemistry is transforming the production landscape for surfactants and emulsifiers. Bio-fermentation processes,
More news about: Market Research Intellect
Apr 14, 2026, 03:49 ET CS Analytical Names Jennifer Roark to Director of Scientific Affairs
cGMP, FDA-registered and inspected contract laboratory exclusively designed and dedicated to package and container testing for the pharmaceutical, biotechnology, and medical device industries is excited to announce the appointment of
More news about: CS Analytical
Apr 14, 2026, 03:00 ET ARTHEx Biotech Announces Participation at the 25th Annual Needham Virtual Healthcare Conference
VALENCIA, Spain, April 14, 2026 /PRNewswire/ -- ARTHEx Biotech, a clinical-stage biotechnology company advancing RNA-based therapeutics for neuromuscular disorders, today announced its participation in the 25th Annual Needham Virtual
More news about: ARTHEx Biotech
Apr 13, 2026, 19:31 ET ImmunityBio, Inc. (IBRX) Facing Securities Class Action Amid FDA Warning Regarding Unsupported Cancer Treatment Claims, $2 Billion Market Capitalization Wiped Out -- Hagens Berman
[email protected] 844-916-0895ImmunityBio, Inc. (IBRX) Securities Class Action: ImmunityBio is a biotechnology company focused on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system
More news about: Hagens Berman Sobol Shapiro LLP
Apr 13, 2026, 11:33 ET Global Biomedical Sensor Market Poised for Strong Growth as Rising Demand for Real-Time Health Monitoring and Advancements in Wearable Technologies Accelerate Adoption: Verified Market Research®
Research, Pharmaceutical and Biotechnology Research, Clinical Diagnostics, Material Science and Nanotechnology, Academic and Research Institutes, Other Applications), By End-User (Hospitals and Clinical Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research
More news about: Verified Market Research
Apr 13, 2026, 11:16 ET AI Eyes Move Onto The Counter-Drone Battlefield As Defense Tech Companies Race To Fuse Video With RF
the combat-proven Puma, Raven, and JUMP 20 platforms. [15] The Company also secured a USD 75 million US Air Force contract for next-generation biotechnology and materials R&D using AI and biomimetics, and helped launch a beyond-visual-line-of-sight airspace management facility in Ohio. [16]The
More news about: USA News Group